Recognition and management of exercise-induced bronchospasm

American Family Physician

Volumn 67, Issue 4, 2003, Pages 769-774+776

  Sinha, Taru ^a,b   David, Alan K ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Mountainside Fam Pract Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BITOLTEROL MESILATE; BUDESONIDE; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE PROPIONATE; FORADIL AEROLIZER; FORMOTEROL FUMARATE; FUROSEMIDE; HEPARIN; IPRATROPIUM BROMIDE; MONTELUKAST; NEDOCROMIL; NEDOCROMIL SODIUM; ORCIPRENALINE; PIRBUTEROL ACETATE; SALBUTAMOL; SALMETEROL; SALMETEROL XINAFOATE; SLO PHYLLIN; TERBUTALINE; THEOPHYLLINE; TRIAMCINOLONE ACETONIDE; ZAFIRLUKAST; ZILEUTON;

AIRFLOW; ALGORITHM; ANAMNESIS; BEHAVIOR DISORDER; BRONCHOSPASM; CLINICAL FEATURE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DIAGNOSTIC PROCEDURE; EPIDEMIOLOGICAL DATA; EXERCISE INDUCED ASTHMA; FITNESS; FORCED EXPIRATORY VOLUME; HOARSENESS; HUMAN; INHALER; LUNG FUNCTION TEST; META ANALYSIS; METERED DOSE INHALER; PROPHYLAXIS; PROVOCATION TEST; REVIEW; SIDE EFFECT; THRUSH; TREADMILL;

ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA, EXERCISE-INDUCED; BRONCHIAL SPASM; CLINICAL TRIALS; CRITICAL PATHWAYS; HUMANS; NEBULIZERS AND VAPORIZERS;

EID: 0037442790     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. National Asthma Education and Prevention Program (National Heart, Lung, and Blood Institute). Guidelines for the diagnosis and management of asthma: expert panel report 2. Bethesda, Md.: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute, 1997; NIH publication no. 97-4051.
2. Kawabori I, Pierson WE, Conquest LL, Bierman CW. Incidence of exercise-induced asthma in children. J Allergy Clin Immunol 1976;58:447-55.
3. Rupp NT, Guill MF, Brudno DS. Unrecognized exercise-induced bronchospasm in adolescent athletes. Am J Dis Child 1992;146:941-4.
4. Randolph C. Exercise-induced asthma: update on pathophysiology, clinical diagnosis, and treatment. Curr Probl Pediatr 1997;27:53-77.
5. Sonna LA, Angel KC, Sharp MA, Knapik JJ, Patton JF, Lilly CM. The prevalence of exercise-induced bronchospasm among US Army recruits and its effects on physical performance. Chest 2001;119:1676-84.
6. Tan RA, Spector SL. Exercise-induced asthma. Sports Med 1998;25:1-6.
7. Reiff DB, Choudry NB, Pride NB, Ind PW. The effect of prolonged submaximal warm-up exercise on exercise-induced asthma. Am Rev Respir Dis 1989;139:479-84.
8. Schnall RP, Landau LI. Protective effects of repeated short sprints in exercise-induced asthma. Thorax 1980;35:828-32.
9. Boulet LP. Long- versus short-acting beta 2-agonists. Implications for drug therapy. Drugs 1994;47:207-22.
10. Ferrari M, Balestreri F, Baratieri S, Biasin C, Oldani V, Lo Cascio V. Evidence of the rapid protective effect of formoterol dry-powder inhalation against exercise-induced bronchospasm in athletes with asthma. Respiration 2000;67:510-3.
11. Vilsvik J, Ankerst J, Palmqvist M, Persson G, Schaanning J, Schwabe G, et al. Protection against cold air and exercise-induced bronchoconstriction while on regular treatment with Oxis. Respir Med 2001;95:484-90.
12. Bisgaard H. Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature. Pediatr Pulmonol 2000;29:221-34.
13. Grove A, Lipworth BJ. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet 1995;346:201-6.
14. Garcia R, Guerra P, Feo F, Galindo PA, Gomez E, Borja J, et al. Tachyphylaxis following regular use of formoterol in exercise-induced bronchospasm. J Investig Allergol Clin Immunol 2001;11:176-82.
15. Cavallo A, Cassaniti C, Glogger A, Magrini H. Action of nedocromil sodium in exercise-induced asthma in adolescents. J Investig Allergol Clin Immunol 1995;5:286-8.
16. Kelly K, Spooner CH, Rowe BH. Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced bronchoconstriction in asthmatics (Cochrane Review). Cochrane Database Syst Rev 2002;(4):CD002731.
17. Mahler DA, Exercise-induced asthma. Med Sci Sports Exerc 1993;25:554-61.
18. Thio BJ, Slingerland GL, Nagelkerke AF, Roord JJ, Mulder PG, Dankert-Roelse JE. Effects of single-dose fluticasone on exercise-induced asthma in asthmatic children: a pilot study. Pediatr Pulmonol 2001;32:115-21.
19. Henriksen JM, Dahl R. Effects of inhaled budesonide alone and in combination with low-dose terbutaline in children with exercise-induced asthma. Am Rev Respir Dis 1983;128:993-7.
20. Tan RA, Spector SL. Exercise-induced asthma: diagnosis and management. Ann Allergy Asthma Immunol 2002;89:226-35.
21. Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 1998;339:147-52.
22. Meltzer SS, Hasday JD, Cohen J, Bleecker ER. Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor. Am J Respir Crit Care Med 1996;153:931-5.
23. Bjermer L, Diamant Z. The use of leukotriene receptor antagonists (LRTAs) as complementary therapy in asthma. Monaldi Arch Chest Dis 2002;57:76-83.
24. Novembre E, Frongia G, Lombardi E, Resti M, Zammarchi E, Vierucci A. The preventive effect and duration of action of two doses of inhaled furosemide on exercise-induced asthma in children. J Allergy Clin Immunol 1995;96:906-9.
25. Cohen HA, Neuman I, Nahum H. Blocking effect of vitamin C in exercise-induced asthma. Arch Pediatr Adolesc Med 1997;151:367-70.
26. Ahmed T, Garrigo J, Danta I. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N Engl J Med 1993;329:90-5.
27. Gotshall RW. Exercise-induced bronchoconstriction. Drugs 2002;62:1725-39.